[LGND] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -3,697.52%
YoY- -192.55%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 32,868 26,366 43,979 50,382 66,088 57,419 45,693 -19.70%
PBT -15,344 3,171 55,536 24,140 857 -636 -20,140 -16.56%
Tax -2,552 881 11,922 38,674 453 259 -4,755 -33.93%
NP -12,792 2,290 41,949 -14,534 404 -895 -15,385 -11.56%
Tax Rate - -27.78% -21.47% -160.21% -52.86% - - -
Total Cost 45,660 24,076 2,030 64,916 65,684 58,314 61,078 -17.61%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -38.92 8.69 95.38 -28.85 0.61 -1.56 -33.67 10.13%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.74 0.13 2.46 -0.86 0.02 -0.05 -0.92 -13.49%
EPS Diluted -0.74 0.13 2.33 -0.86 0.02 -0.05 -0.91 -12.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.